Table 1 Datasets
Dataset | Disease | Samples | Samples per phenotype | Source |
|---|---|---|---|---|
Swindell [65] | Psoriasis | 180 | Healthy control: 64; | GSE13355 |
Psoriatic non-lesional skin: 58; | ||||
Psoriatic lesional skin: 58 | ||||
Yao [66] | Psoriasis | 82 | Healthy control: 21; | GSE14905 |
Psoriatic non-lesional skin: 28; | ||||
Psoriatic lesional skin: 33 | ||||
Farmer [67] | Breast cancer | 49 | Apocrine tumour: 6; | GSE1561 |
Basal tumour: 16; | ||||
Luminal tumour: 27 | ||||
Pawitan [68] | Breast cancer | 139 | Normal: 37; | GSE1456 |
Luminal tumour: 62; | ||||
ERBB2: 15; | ||||
Basal: 25 | ||||
Singh [3] | Prostate cancer | 102 | Normal: 50; | |
Tumour: 52 | ||||
Shipp [63] | DLBCL | 77 | DLBCL: 58; | |
Follicular lymphoma: 19 | ||||
Popovici [8] | Breast cancer | 230 | Residual invasive cancer: 182; | GSE24061 |
No residual invasive cancer: 48 | ||||
Desmedt [4] | Breast cancer | 198 | Metastatic: 51; | GSE7390 |
Non-metastatic: 147 |